Ampio Pharmaceuticals (NYSE:AMPE) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Thursday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Trading Down 55.6 %

Shares of AMPE opened at $0.04 on Thursday. Ampio Pharmaceuticals has a twelve month low of $0.04 and a twelve month high of $8.30. The firm has a market capitalization of $45,600.00, a P/E ratio of 0.00 and a beta of 2.20. The firm’s 50-day moving average is $0.16 and its two-hundred day moving average is $0.90.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.